Size Matters in Prostate Cancer Treatment
Posted on: Friday, 21 March 2008, 15:00 CDT
Men with prostate cancer should consider prostate size and if the patient has urinary symptoms before choosing a treatment, a U.S. study found.
Previous studies on which prostate cancer treatment to seek -- prostate surgery, external radiation or radioactive seeds -- involve problems with sexuality, bowel problems and problems with urinary incontinence after prostate cancer treatment.
However, Dr. Martin G. Sanda of Beth Israel Deaconess Medical Center and Harvard Medical School in Boston said that a research team involving nine hospital found other symptoms, such as frequent or weak urination, are equally as important in determining patient satisfaction.
The study of 1,201 men and 625 spouses also found that overall satisfaction with treatment was lower among African-American men, despite their having received care at the same centers as their white counterparts, Sanda said.
Researchers found that hormonal therapy, when combined with brachytherapy or with external radiation, worsened multiple aspects of quality-of-life. Patients receiving radioactive seed treatment experienced problems with weak or frequent urination which had greater effect on overall satisfaction than previously appreciated.
Some with prostates removed surgically reported urinary incontinence and sexual side effects.
The finding were published in the New England Journal of Medicine.
Source: United Press International
Related Articles
- Study Shows Seed Implants A Suitable Prostate Cancer Treatment Option For Men Of All Ages
- EUSA Pharma Completes the European Launch of CAPHOSOL(R) for Prevention and Treatment of Oral Mucositis Caused by Cancer Therapy
- Sexual Intimacy A Problem For Young Breast Cancer Survivors
- AstraZeneca's Zactima to Earn Almost Five Percent Patient Share in the Treatment of Non-Small-Cell Lung Cancer By 2016
- GSK Receives Approval for HYCAMTIN(R) (Topotecan) Capsules for the Treatment of Relapsed Small Cell Lung Cancer
- Leading Oncology Treatment and Research Groups Establishing Comprehensive Cancer Center
- Nymox Records Minimal Side Effects in Prostate Treatment
- 2 Men With Brain Cancer Sue Chemical Plants
- Novartis Completes Submissions in US and Europe for Gleevec(R) As Treatment for Four Rare Types of Cancer
- New Study Argues for Early Prostate Treatment
User Comments (0)

RSS Feeds